About Us


GSK is focused on maximizing patient survival through transformational medicines. GSK’s pipeline is focused on immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality. Our goal is to achieve a sustainable flow of new treatments based on a diversified portfolio of investigational medicines utilizing modalities such as small molecules, antibodies, antibody drug conjugates and cell therapy, either alone or in combination.

Contact Us

Together with GSK Oncology

1-844-4GSK-ONC (1-844-447-5662


GSK Response Center